forasartan has been researched along with tetrodotoxin in 1 studies
| Studies (forasartan) | Trials (forasartan) | Recent Studies (post-2010) (forasartan) | Studies (tetrodotoxin) | Trials (tetrodotoxin) | Recent Studies (post-2010) (tetrodotoxin) |
|---|---|---|---|---|---|
| 15 | 1 | 0 | 12,992 | 11 | 1,477 |
| Protein | Taxonomy | forasartan (IC50) | tetrodotoxin (IC50) |
|---|---|---|---|
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 0.0186 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, T; Usune, S | 1 |
1 other study(ies) available for forasartan and tetrodotoxin
| Article | Year |
|---|---|
Effects of SC-52458, a new nonpeptide angiotensin II receptor antagonist, on increase in cytoplasmic Ca2+ concentrations and contraction induced by angiotensin II and K(+)-depolarization in guinea-pig taenia coli.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atropine; Calcium; Colon; Cytoplasm; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neuromuscular Depolarizing Agents; Parasympatholytics; Potassium; Pyridines; Tetrazoles; Tetrodotoxin | 1996 |